50 employees
EnGeneIC develops and commercializes the treatment of cancer through the targeted delivery of therapeutic agents directly to cancer cells.
2000
$10M
from 2 investors over 2 rounds
EnGeneIC Ltd raised $10M on January 6, 2015
Investors: Foley Ventures Inc and Shepherd Kaplan Krochuk, LLC